Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 29 out of 100. Clinical safety

Topic: Risk, prevention and care in population studies

Plain-language summary

The CVI of PAINAD-Th was 1.00 for forward translation and 0.93 for back translation. The PAINAD-Th showed strong correlations with the reference standard (rs=0.854–0.943, p-value <0.001). The inter-rater agreement for the total scores was 0.937 and 0.955, and the test-retest reliabilities were 0.914 to 0.964 for the activity stage and 0.880 for the resting stage, respectively. The concurrent validity index did not vary significantly across different stages of dementia; the findings remained consistent in the delirium subgroup analysis. The PAINAD-Th is a valuable tool for evaluating pain in PwD, not only in severe dementia but also in moderately severe stage, regardless of concurrent delirium. It also demonstrated good-to-excellent concurrent validity, inter-rater reliability, and test-retest reliability.

What this study adds

Evidence grade: Low

This study found the Thai version of the PAINAD scale showed good-to-excellent validity and reliability for assessing pain in people with moderately severe dementia, including those with concurrent delirium. It evaluates a pain assessment tool and does not test any treatment, cure or prevention for Alzheimer's disease.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Boonsawat, N., Suraarunsumrit, P., Pitiyarn, S., Pengsorn, N., Srinonprasert, V., Mandee, S., et al. (2025). Reliability and Validity of the Thai Version of the PAINAD Scale: An Extended Application of Pain Assessment in the Moderately Severe Stage of Dementia. Siriraj Medical Journal/San Sirirat. https://doi.org/10.33192/smj.v77i1.271644

Vancouver

Boonsawat N, Suraarunsumrit P, Pitiyarn S, Pengsorn N, Srinonprasert V, Mandee S, et al. Reliability and Validity of the Thai Version of the PAINAD Scale: An Extended Application of Pain Assessment in the Moderately Severe Stage of Dementia. Siriraj Medical Journal/San Sirirat. 2025. doi:10.33192/smj.v77i1.271644.

BibTeX

@article{boonsawat2025-c1c58c9c,
  author  = {Boonsawat, Natthapapath and Suraarunsumrit, Patumporn and Pitiyarn, Sutisa and Pengsorn, Napaporn and Srinonprasert, Varalak and Mandee, Sahatsa and Wongviriyawong, Titima},
  title   = {{Reliability and Validity of the Thai Version of the PAINAD Scale: An Extended Application of Pain Assessment in the Moderately Severe Stage of Dementia}},
  journal = {Siriraj Medical Journal/San Sirirat},
  year    = {2025},
  doi     = {10.33192/smj.v77i1.271644},
  url     = {https://doi.org/10.33192/smj.v77i1.271644}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

This study found the Thai version of the PAINAD scale showed good-to-excellent validity and reliability for assessing pain in people with moderately severe dementia, including those with concurrent delirium. It evaluates a pain assessment tool and does not test any treatment, cure or prevention for Alzheimer's disease.

Study details

How this study scored 29/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 0 of 4; Institution's track record 0 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. Total 29 of 100.29 of 100 points earned71 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Siriraj Medical Journal/San Sirirat)
Journal's citation record 0 / 4 Siriraj Medical Journal/San Sirirat: journal h-index 14 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.3 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.1× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 0 / 4 Last-listed author Titima Wongviriyawong: h-index 4 (OpenAlex, whole career)
Institution's track record 0 / 3 Mahidol University: institution h-index 515 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Total 29 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Clinical safety from nearby years

Also tagged “prevalence”

1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Clinical safety

See all studies in Clinical safety →